Dogwood Therapeutics DWTX Unrealized Gain (Loss), Foreign Currency Transaction, before Tax
Unrealized Gain (Loss), Foreign Currency Transaction, before Tax at other companies
Other financials
Where this comes from
Reported directly by Dogwood Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ForeignCurrencyTransactionGainLossUnrealized.
The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's unrealized gain (loss), foreign currency transaction, before tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dogwood Therapeutics's unrealized gain (loss), foreign currency transaction, before tax?
- Dogwood Therapeutics (DWTX) reported unrealized gain (loss), foreign currency transaction, before tax of -$5.86K in Q1 2026.
- How has Dogwood Therapeutics's unrealized gain (loss), foreign currency transaction, before tax changed year-over-year?
- Dogwood Therapeutics's unrealized gain (loss), foreign currency transaction, before tax increased by 14.9% year-over-year, from -$6.89K to -$5.86K.
- What does unrealized gain (loss), foreign currency transaction, before tax mean?
- Represents the non-cash impact of fluctuations in exchange rates on monetary assets and liabilities denominated in foreign currencies. This metric reflects gains or losses that have not yet been realized through actual settlement of the underlying transactions. It is essential for understanding the volatility of international operations and currency exposure.